Patterns of use for brand-name versus generic oral bisphosphonate drugs in Ontario over a 13-year period: a descriptive study

BACKGROUND: Bisphosphonates are the first-line therapy for the treatment of osteoporosis. In the province of Ontario, the Ontario Drug Benefit Program funds medications for patients aged 65 years and older. The Ontario Drug Benefit Program has a generic substitution policy that requires lower-cost g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CMAJ Open
Main Authors: Fraser, Lisa-Ann, Albaum, Jordan M., Tadrous, Mina, Burden, Andrea M., Shariff, Salimah Z., Cadarette, Suzanne M.
Formato: Artigo
Idioma:Inglês
Publicado em: 8872147 Canada Inc. 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4382038/
https://ncbi.nlm.nih.gov/pubmed/25844376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.2014-0090
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados